Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Long-term survival after definitive proton beam therapy for oligorecurrent esophageal squamous cell carcinoma: a case report.

07/02/2022
/ Publications
/
Chemotherapy

A group of researchers from Japan reported a rare case of oligorecurrent esophageal cancer in complete remission for 5 years after a course of definitive proton...

Treating breast cancer with proton therapy

23/04/2019
/ White Paper

Breast cancer (BC) is now the most commonly diagnosed cancer in women. Worldwide, an...

Proton therapy in Groningen: clinical practice and future perspectives

09/08/2021
/ Event
/
Model-based approach
Ramp-up
  • Overview of the clinical practice of proton therapy in Groningen, The Netherlands:
  • - Evolution of the number of patients per indication
  • - Model-based...

Treating thoracic cancers with proton therapy

05/06/2019
/ White Paper
/
Chemotherapy

Worldwide, lung cancer is the most common cancer among men in both incidence and...

Proton Beam Therapy versus Photon Radiotherapy for Stage I Non-Small Cell Lung Cancer.

13/09/2022
/ Publications
/
Dosimetry

Published by the NCC group, Korea, this study reported clinical outcomes and dosimetry comparison of 289 patients with stage I NSCLC treated with protons (n=112...

Treating Hodgkin and non-Hodgkin lymphoma with proton therapy

22/12/2020
/ White Paper
/
Pencil Beam Scanning - PBS
VMAT

Proton therapy is different from photon-based radiotherapy. Because of their unique physical properties, protons have no ‘exit’ dose and very little ‘entrance’...

High-dose Intensity-modulated proton therapy versus Standard-dose Intensity-modulated RadIation therapy for esophageal squamous cell carcinoma (HI-SIRI): study protocol for a randomized controlled clinical trial.

15/11/2022
/ Publications
/
IMPT
IMRT

This is a study protocol details a randomized trial taking place in Thailand with multiple centers comparing IMPT and IMRT for stage II–IVA squamous thoracic...

Proton Beam Therapy for Esophageal Cancer.

15/11/2022
/ Publications
/
Clinical Trial

A latest review examined the existing of PBT for locally advanced esophageal cancer, including dosimetric comparative studies, early clinical outcome...

Hypofractionated proton therapy for non-small cell lung cancer: Ready for prime time? A systematic review and meta-analysis.

15/11/2022
/ Publications
/
Hypofractionation

This systematic review evaluated eight studies and 401 patients with early stage NSCLC treated with hypofractionated PBT to a median total dose of 63 Gy(RBE)...

Cardiopulmonary Toxicity Following Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiation Therapy (IMRT) for Stage III Non-Small Cell Lung Cancer.

15/11/2022
/ Publications
/
IMPT
IMRT

163 consecutively treated patients with biopsy-proven, stage III NSCLC who received IMPT (n = 35, 21%) or IMRT (n = 128, 79%) were analyzed in this study...